EDIT earnings: a negative outcome, -11.4%

On May 8, 2024, Editas Medicine, Inc. reached its earnings. The result was a negative outcome, and the stock moved -11.4% in the window around the event. It had already run -15.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.